[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:c-x-c-motif-chemokine-9":3},{"name":4,"total":5,"recruiting":6,"trials":7},"C-X-C Motif Chemokine 9",4,2,[8,16,23,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT00107289","Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma",[12],"Phase 2","RECRUITING","2026-08-26T02:15:02.712396Z","2026-05-05T02:43:27.512726Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07025538","Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation",[20],"Phase 1","2026-08-26T02:16:34.792807Z","2026-04-29T02:57:57.116813Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT07538336","Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction",[12],"NOT_YET_RECRUITING","2026-08-26T02:18:49.989941Z","2026-05-05T02:43:27.259622Z",{"nct_id":31,"title":32,"phases":33,"status":27,"updated_at":34,"content_modified":35},"NCT07661420","211At-MABG in Adults With Advanced Neuroendocrine Cancers",[20],"2026-08-26T02:16:57.705506Z","2026-07-05T03:45:20.260334Z"]